Emergency care of patients receiving non-vitamin K antagonist oral anticoagulants

被引:14
作者
Eikelboom, J. W. [1 ,2 ]
Kozek-Langenecker, S. [3 ]
Exadaktylos, A. [4 ]
Batorova, A. [5 ,6 ]
Boda, Z. [7 ]
Christory, F. [8 ]
Gornik, I. [9 ,23 ]
Kekstas, G. [10 ]
Kher, A. [11 ]
Komadina, R. [12 ]
Koval, O. [13 ]
Mitic, G. [14 ,15 ]
Novikova, T. [16 ,17 ]
Pazvanska, E. [18 ]
Ratobilska, S. [19 ]
Sutt, J. [20 ]
Winder, A. [21 ]
Zateyshchikov, D. [22 ]
机构
[1] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada
[2] Hamilton Hlth Sci, Hamilton, ON, Canada
[3] Evangel Hosp Vienna, Dept Anaesthesia & Intens Care, Vienna, Austria
[4] Bern Univ Hosp, Inselspital, Dept Emergency Med, Bern, Switzerland
[5] Comenius Univ, Fac Med, Dept Haematol & Transfus Med, Bratislava, Slovakia
[6] Univ Hosp, Bratislava, Slovakia
[7] Univ Debrecen, Thrombosis & Haemostasis Ctr, Dept Internal Med, Debrecen, Hungary
[8] Med Educ Global Solut, Paris, France
[9] Univ Hosp Ctr Zagreb, Dept Med, Intens Care Unit, Zagreb, Croatia
[10] Vilnius Univ, Hosp Santariskiu Klin, Dept Anaesthesiol & Intens Care, Vilnius, Lithuania
[11] Hotel Dieu Univ Hosp, Lab Biol Hematol, Paris, France
[12] Gen & Teaching Hosp Celje, Dept Traumatol, Celje, Slovenia
[13] Dnipropetrovsk State Med Acad, Dept Hosp Therapy 2, Dnepropetrovsk, Ukraine
[14] Univ Novi Sad, Clin Ctr Vojvodina, Ctr Lab Med, Thrombosis & Haemostasis Unit, Novi Sad, Serbia
[15] Univ Novi Sad, Fac Med, Novi Sad, Serbia
[16] Northwestern Med Univ II Mechnikov, Dept Cardiol, St Petersburg, Russia
[17] Pokrovskaya City Hosp, Vasc Ctr, St Petersburg, Russia
[18] 4th City Hosp, Dept Anaesthesia & Intens Care, Sofia, Bulgaria
[19] Pauls Stradins Clin Univ Hosp, Intens Care Unit, Riga, Latvia
[20] Tartu Univ Hosp, Anaesthesiol & Intens Care Clin, Tartu, Estonia
[21] Wolfson Med Ctr, Dept Hematol, Thrombosis & Hemostasis Unit, Holon, Israel
[22] City Clin Hosp 51, Primary Vasc Dept, Moscow, Russia
[23] Univ Zagreb, Sch Med, Zagreb, Croatia
关键词
anticoagulants; coagulation monitoring; emergencies; haemorrhage; reversal; PROTHROMBIN COMPLEX CONCENTRATE; ACTIVATED FACTOR-VII; COAGULATION ASSAYS; THROMBIN GENERATION; VISCOELASTIC COAGULATION; DABIGATRAN ETEXILATE; EUROPEAN-SOCIETY; ANDEXANET ALPHA; PRACTICAL GUIDE; IN-VITRO;
D O I
10.1016/j.bja.2017.11.082
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Non-vitamin K antagonist oral anticoagulants (NOACs), which inhibit thrombin (dabigatran) and factor Xa (rivaroxaban, apixaban, edoxaban) have been introduced in several clinical indications. Although NOACs have a favourable benefit-risk profile and can be used without routine laboratory monitoring, they are associatedeas any anticoagulantewith a risk of bleeding. In addition, treatment may need to be interrupted in patients who need surgery or other procedures. The objective of this article, developed by a multidisciplinary panel of experts in thrombosis and haemostasis, is to provide an update on the management of NOAC-treated patients who experience a bleeding episode or require an urgent procedure. Recent advances in the development of targeted reversal agents are expected to help streamline the management of NOAC-treated patients in whom rapid reversal of anticoagulation is required.
引用
收藏
页码:645 / 656
页数:12
相关论文
共 81 条
[61]   Determination of dabigatran, rivaroxaban and apixaban by ultra-performance liquid chromatography - tandem mass spectrometry (UPLC-MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants [J].
Schmitz, E. M. H. ;
Boonen, K. ;
van den Heuvel, D. J. A. ;
van Dongen, J. L. J. ;
Schellings, M. W. M. ;
Emmen, J. M. A. ;
van der Graaf, F. ;
Brunsveld, L. ;
van de Kerkhof, D. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (10) :1636-1646
[62]   Idarucizumab does not have procoagulant effects: Assessment of thrombosis biomarkers in healthy volunteers [J].
Schmohl, Michael ;
Glund, Stephan ;
Harada, Akiko ;
Imazu, Susumu ;
De Smet, Marina ;
Moschetti, Viktoria ;
Ramael, Steven ;
Ikushima, Ippei ;
Gruenenfelder, Fredrik ;
Reilly, Paul ;
Stangier, Joachim .
THROMBOSIS AND HAEMOSTASIS, 2017, 117 (02) :269-276
[63]   Activated prothrombin complex concentrate for dabigatran-associated bleeding [J].
Schulman, Sam ;
Ritchie, Bruce ;
Goy, Jennifer K. ;
Nahirniak, Susan ;
Almutawa, Mohammad ;
Ghanny, Shari .
BRITISH JOURNAL OF HAEMATOLOGY, 2014, 164 (02) :308-310
[64]   Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial [J].
Shakur, Haleema ;
Roberts, Ian ;
Bautista, Raul ;
Caballero, Jose ;
Coats, Tim ;
Dewan, Yashbir ;
El-Sayed, Hesham ;
Gogichaishvili, Tamar ;
Gupta, Sanjay ;
Herrera, Jorge ;
Hunt, Beverley ;
Iribhogbe, Pius ;
Izurieta, Mario ;
Khamis, Hussein ;
Komolafe, Edward ;
Marrero, Maria-Acelia ;
Mejia-Mantilla, Jorge ;
Miranda, Jaime ;
Morales, Carlos ;
Olaomi, Oluwole ;
Dashi, Fatos ;
Perel, Pablo ;
Peto, Richard ;
Ramana, P. V. ;
Ravi, R. R. ;
Yutthalcasemsunt, Surakrant ;
Dakubo, Jonathan ;
Gogichaishvili, Tamar ;
Golden, Nyoman ;
Izurieta, Mario ;
Khamis, Hussein ;
Komolafe, Edward ;
Loria-Castellanos, Jorge ;
Mejia-Mantilla, Jorge ;
Miranda, Jaime ;
Munoz, Angeles ;
Mutiso, Vincent ;
Olcwen, Patrick ;
Ortiz, Zulma ;
Pascual, Maria ;
Ravi, R. ;
Roslani, April ;
Trenkler, Stefan ;
Volpi, Annalisa ;
Yutthakasemsunt, Surakrant ;
Roberts, Ian ;
Shakur, Haleema ;
Perel, Pablo ;
Bametson, Lin ;
Ramos, Maria .
LANCET, 2010, 376 (9734) :23-32
[65]   Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation [J].
Sherwood, Matthew W. ;
Douketis, James D. ;
Patel, Manesh R. ;
Piccini, Jonathan P. ;
Hellkamp, Anne S. ;
Lokhnygina, Yuliya ;
Spyropoulos, Alex C. ;
Hankey, Graeme J. ;
Singer, Daniel E. ;
Nessel, Christopher C. ;
Mahaffey, Kenneth W. ;
Fox, Keith A. A. ;
Califf, Robert M. ;
Becker, Richard C. .
CIRCULATION, 2014, 129 (18) :1850-1859
[66]   Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity [J].
Siegal, Deborah M. ;
Curnutte, John T. ;
Connolly, Stuart J. ;
Lu, Genmin ;
Conley, Pamela B. ;
Wiens, Brian L. ;
Mathur, Vandana S. ;
Castillo, Janice ;
Bronson, Michele D. ;
Leeds, Janet M. ;
Mar, Florie A. ;
Gold, Alex ;
Crowther, Mark A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (25) :2413-2424
[67]   Reversal of target-specific oral anticoagulants [J].
Siegal, Deborah M. ;
Cuker, Adam .
DRUG DISCOVERY TODAY, 2014, 19 (09) :1465-1470
[68]   How I treat target-specific oral anticoagulant-associated bleeding [J].
Siegal, Deborah M. ;
Garcia, David A. ;
Crowther, Mark A. .
BLOOD, 2014, 123 (08) :1152-1158
[69]   Reversal of novel oral anticoagulants in patients with major bleeding [J].
Siegal, Deborah M. ;
Cuker, Adam .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2013, 35 (03) :391-398
[70]   Thrombelastography detects dabigatran at therapeutic concentrations in vitro to the same extent as gold-standard tests [J].
Solbeck, Sacha ;
Ostrowski, Sisse R. ;
Stensballe, Jakob ;
Johansson, Par I. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 208 :14-18